Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Caremark Takes Measured Approach In “Go To Market” Strategies

Executive Summary

CVS Caremark is in the process of introducing new "cross-functional" products and services to its health plan clients, CEO Thomas Ryan said during the firm's second quarter earnings call Aug. 2

You may also be interested in...



CVS Caremark Expanding Retail Access To Specialty Drugs

CVS Caremark is moving to increase its specialty drug sales with two new in-store services. The firm discussed the initiatives during its investor day presentation May 21

CVS Caremark Expanding Retail Access To Specialty Drugs

CVS Caremark is moving to increase its specialty drug sales with two new in-store services. The firm discussed the initiatives during its investor day presentation May 21

CVS Suit Against Prasco Illustrates Pricing Leverage From Caremark Merger

A lawsuit by CVS Caremark against generic drug manufacturer Prasco illustrates the potential cross-market leverage that the combined pharmacy/PBM entity is able to wield

UsernamePublicRestriction

Register

PS048643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel